Jane Street
TRAW icon

Jane Street’s Traws Pharma TRAW Stock Holding History

Jane Street’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
216,006
+194,765
+917% +$268K ﹤0.01% 10196
2026
Q1 		$38.9K Buy
+21,241
New +$39.9K ﹤0.01% 11049
2024
Q3 		– Sell
-1,002
Closed -$11.2K – 10561
2024
Q2 		$11.2K Buy
+1,002
New +$16.1K ﹤0.01% 9101
2023
Q2 		– Sell
-412
Closed -$7.53K – 9719
2023
Q1 		$7.53K Sell
412
-194
-32% -$4.2K ﹤0.01% 8768
2022
Q4 		$9.79K Buy
+606
New +$11.4K ﹤0.01% 8767
2022
Q3 		– Sell
-599
Closed -$20K – 10626
2022
Q2 		$20K Buy
+599
New +$20.2K ﹤0.01% 9163
2020
Q4 		– Sell
-305
Closed -$32K – 8227
2020
Q3 		$32K Buy
305
+172
+129% +$42.5K ﹤0.01% 6982
2020
Q2 		$28K Buy
+133
New +$20.3K ﹤0.01% 6938

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street's TRAW Position: Q2 2026 in Review

Jane Street increased its Traws Pharma (TRAW) stake by 917% in Q2 2026, buying an estimated $268K and bringing the position to 216,006 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #10196.

Jane Street first reported a position in TRAW in Q2 2020 and has held it in 8 quarters since. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Jane Street held 216,006 shares of Traws Pharma worth $182K as of Q2 2026.
  • Jane Street bought 194,765 Traws Pharma shares in Q2 2026, an estimated $268K.
  • Traws Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10196 holding.
  • Jane Street first reported a position in Traws Pharma in Q2 2020 and has held it in 8 quarters since.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.